Issue 32, 2015

Towards more drug-like proteomimetics: two-faced, synthetic α-helix mimetics based on a purine scaffold

Abstract

Mimicry of two faces of an α-helix might yield more potent and more selective inhibitors of aberrant, helix-mediated protein–protein interactions (PPI). Herein, we demonstrate that a 2,6,9-tri-substituted purine is capable of disrupting the Mcl-1-Bak-BH3 PPI through effective mimicry of key residues on opposing faces of the Bak-BH3 α-helix.

Graphical abstract: Towards more drug-like proteomimetics: two-faced, synthetic α-helix mimetics based on a purine scaffold

Supplementary files

Article information

Article type
Communication
Submitted
11 Mar 2015
Accepted
09 Jul 2015
First published
09 Jul 2015

Org. Biomol. Chem., 2015,13, 8642-8646

Author version available

Towards more drug-like proteomimetics: two-faced, synthetic α-helix mimetics based on a purine scaffold

M. E. Lanning, P. T. Wilder, H. Bailey, B. Drennen, M. Cavalier, L. Chen, J. L. Yap, M. Raje and S. Fletcher, Org. Biomol. Chem., 2015, 13, 8642 DOI: 10.1039/C5OB00478K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements